Top Markets
Coin of the day
Idogen AB (publ) Idogen AB (publ)

Idogen AB (publ)

IDOGEN
Clasificación en acciones #37811
Idogen AB (publ) is a Swedish biotechnology company specializing in the... Idogen AB (publ) is a Swedish biotechnology company specializing in the development of tolerogenic cell therapies. These innovative treatments are engineered to prevent a patient's immune system from attacking crucial elements, including biological agents, transplanted organs, and the body's own cells or tissues. The company's most advanced product in development is IDO 8, designed for individuals with severe haemophilia A who have developed neutralizing antibodies against their vital coagulation factor VIII treatment. Idogen is also developing IDO T, a tolerogenic cell therapy intended to prevent organ transplant rejection, primarily for kidney transplants, and IDO AID, aimed at treating autoimmune diseases. Established in 2008, the company is headquartered in Lund, Sweden.
Precio por acción
$0.01345907
Última sincronización: 2024-07-12
Capitalización bursátil
$1.43M
Cambio (1 día)
22.16%
Cambio (1 año)
0.00%
País
SE
Comercio Idogen AB (publ) (IDOGEN)

Categoría

Historial de rendimiento por dividendo de Idogen AB (publ) (IDOGEN)
Rendimiento por dividendo (TTM) de Idogen AB (publ) (símbolo bursátil: IDOGEN) al 2026: 0
Rendimiento promedio por dividendo de los últimos 5 años: 0.00%
Historial de rendimiento por dividendo de Idogen AB (publ) (IDOGEN) desde 2026 hasta 2026
Rendimiento por dividendo al final de cada año (TTM)
Año Rendimiento por dividendo Cambiar
Not enough data for the provided dates.
Rendimientos por dividendo (TTM) de empresas similares o competidoras
Empresa Rendimiento por dividendo País
0.00%
US
0.00%
NL
0.00%
CH
0.00%
KR
0.65%
BE